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I read with interest the manuscript entitled: ‘Epileptiform
discharges relate to altered functional brain networks in
autism spectrum disorders’, written by Dr Tetsu
Hirosawa and colleagues. The authors demonstrated that
alterations of functional brain networks in children with
autism spectrum disorder (ASD) depend on the existence
of interictal epileptiform discharges.1
Here, I would like to re-emphasize the relationship between interictal epileptiform discharges and cognitive
and intellectual problems that are often associated with
ASD and propose a research strategy using electroencephalography (EEG) to probably unlock some of the
mystery around the cognitive problems in ASD. Usually,
and sometimes mistakenly, we assume that something
that is common is normal or is not significant! We already know that many patients with ASD may have epileptic seizures or EEG abnormalities without seizures.2,3
When patients have clinical seizures, we usually start
treatment with anti-seizure medications; but, when
patients do not have any clinical seizures, we often assume that EEG abnormalities are not significant and
should not be treated.
However, recent evidence, including the article by
Hirosawa et al.,1 has shed light on some of the mysteries
around the occurrence of abnormal EEG findings in
patients with intellectual disabilities (including ASD) and
without clinical seizures.1,4 These findings may have important clinical implications. Firstly, there is a significant
negative correlation between interictal epileptiform activity and cognitive performance.5 It seems that interictal
spikes directly disrupt the functional brain networks responsible for behaviour and cognition.5,6 Secondly, some

anti-seizure medications (e.g. levetiracetam) may affect
interictal epileptiform discharges and are associated with
improvements in EEG background and cognitive function
in children with epilepsy and cognitive dysfunction.6,7
As a result, maybe we should consider performing a
screening EEG in all patients with ASD and adding abnormal EEG in patients with ASD to the list of exceptions to the adage ‘Treat the patient, not the EEG’.
However, whether EEG screening is cost-effective and is
indicated in all patients with ASD and whether treatment
of interictal epileptiform discharges in patients with ASD
(and without clinical seizures) is indicated to improve
their cognitive problems should be tested in double-blind
randomized clinical trials.
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